XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.1
COMMON STOCK AND EARNINGS PER SHARE (Tables)
3 Months Ended
Mar. 31, 2023
COMMON STOCK AND EARNINGS PER SHARE  
Schedule of computation of earnings per share

The following is a reconciliation of basic and diluted earnings per common share for each of the periods presented (in thousands, except share and per share data):

Three Months Ended

    

March 31,
2023

    

March 31,
2022

Basic and Diluted Earnings:

Net Loss Attributable to Common Stockholders, Used in Basic EPS

$

(7,188)

$

(993)

Add Back: Effect of Dilutive Interest Related to 2025 Notes (1)

Net Loss Attributable to Common Stockholders, Used in Diluted EPS

(7,188)

(993)

Basic and Diluted Shares:

Weighted Average Shares Outstanding, Basic

22,704,829

17,726,677

Common Shares Applicable to Dilutive Effect of 2025 Notes (2)

Weighted Average Shares Outstanding, Diluted

22,704,829

17,726,677

Per Share Information:

Net Loss Attributable to Common Stockholders

Basic and Diluted

$

(0.32)

$

(0.06)

(1)

As applicable, includes interest expense, amortization of discount, amortization of fees, and other changes in net income or loss that would result from the assumed conversion of the 2025 Convertible Senior Notes to derive FFO (as defined herein) effective January 1, 2022 due to the implementation of ASU 2020-06 which requires presentation on an if-converted basis. For the three months ended March 31, 2023 and 2022, a total of $0.5 million and $0.6 million of interest was not included, respectively, as the impact of the 2025 Notes, if-converted, would be antidilutive to the net loss attributable to common stockholders of $7.2 million and $1.0 million, respectively.

(2)

A total o3.2 million and 3.0 million shares, representing the dilutive impact of the 2025 Notes, upon adoption of ASU 2020-06 effective January 1, 2022, were not included in the computation of diluted net loss attributable to common stockholders for the three months ended March 31, 2023 and 2022, respectively, because they were antidilutive to the net loss attributable to common stockholders of $7.2 million and $1.0 million, respectively.